COMP <GO>
WRBY vs AXGN // 10Y YIELD & FRED MACRO BETA
Warby Parker Inc. (NYSE) VS. Axogen Inc. (NASDAQ) • 15-METRIC TALLY: WRBY 7
— AXGN 4
▲ 10Y YIELD & FRED MACRO BETA LEADER: WRBY
LAST: $24.59 (+0.66%) • MKT CAP: $3.04B
macro-sensitivity
1.14
LAST: $49.63 (+0.77%) • MKT CAP: $2.96B
macro-sensitivity
1.10
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WRBY VS. AXGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WRBY | AXGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.00% | 74.30% | -20.30 | AXGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.70% | -2.60% | +0.90 | WRBY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.44% | -0.10% | +1.54 | WRBY | /fcf-yield <GO> |
| Operating Margin | -0.60% | -3.50% | +2.90 | WRBY | /operating-margins <GO> |
| Net Profit Margin | 0.20% | -7.00% | +7.20 | WRBY | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 20.20% | -7.20 | AXGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.35 | 18.64 | -13.29 | AXGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | WRBY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 74.3 | -28.50 | AXGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.14 | 1.10 | +0.04 | WRBY | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.04B | $2.96B | $75.1M | WRBY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WRBY REV | AXGN REV | WRBY GROSS % | AXGN GROSS % | WRBY FCF | AXGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $871.9M | $225.2M | 54.0% | 74.3% | $43.7M | -$2.9M |
| FY 2024 | $771.3M | $187.3M | 55.3% | 75.8% | $34.7M | $1.4M |
| FY 2023 | $669.8M | $159.0M | — | — | $30.9M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WRBY // BETA 1.14
AXGN // BETA 1.10